Navigation Links
Omeros Announces Clinical Development Programs for OMS103HP and OMS302
Date:5/19/2011

utcomes measure used in the successful Phase 2 meniscectomy trial.

OMS302 will be evaluated for safety and efficacy in patients undergoing intra-ocular lens replacement surgery. The trials will enroll both cataract surgery and refractive lens exchange patients. This clinical program will involve two randomized, double-blind, placebo-controlled, multicenter trials. The first trial will be conducted in North America and data are expected in the first half of 2012.  Omeros will initiate the second trial in Europe following discussions with regulators to ensure that data collected meet European expectations for marketing approval. The co-primary endpoints for these trials – maintenance of intraoperative pupil dilation (mydriasis) and reduction of postoperative pain – are the same as those achieved in the recently completed 221-patient Phase 2b trial.

Omeros' OMS103HP Program

OMS103HP is Omeros' PharmacoSurgery™ product candidate being developed for use during arthroscopic procedures, including partial meniscectomy surgery, and was designed to provide a multimodal approach to preemptively block the inflammatory cascade induced by arthroscopy. OMS103HP is a proprietary combination of anti-inflammatory/analgesic active pharmaceutical ingredients (APIs), each with well-known safety and pharmacologic profiles. Each of the APIs are components of generic, FDA-approved drugs that have been marketed in the United States as over-the-counter or prescription drug products for over 15 years and have established and well-characterized safety profiles.

In a Phase 2 clinical trial that evaluated OMS103HP in patients undergoing partial meniscectomy surgery, OMS103HP provided clinically meaningful and significantly greater efficacy than vehicle as measured by patient-reported functional scores using the Knee Injury and Osteoarthritis Outcome Score (KOOS), passive knee flexion and visual analog scale pain scores. The patient-
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Corporation Reports First Quarter 2011 Financial Results
2. Omeros Announces Expansion of Potential Indications for PDE7 Inhibitors
3. Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences
4. Omeros Reports Outcome of Phase 3 Trials of OMS103HP
5. Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results
6. Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders
7. Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
8. Omeros Announces Publication of Data From Antifibrinolytic Program
9. Omeros Licenses Novel Antifibrinolytic Agents
10. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
11. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... 5 Reportlinker.com announces that a new market ... Nanobiotechnologies- applications, markets and companies ... SummaryNanotechnology is the creation and utilization of ... matter on the nanometer-length scale (a nanometer is ...
... DALLAS, Oct. 5 North American Spine is pleased ... in Houston, TX to bring back pain relief to ... by North American Spine will perform the revolutionary ... pain.  Currently, doctors trained by North American Spine are ...
Cached Medicine Technology:Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 3Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 4Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 5Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 6Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 7Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 8Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 9Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 10Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 11Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 12Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 13Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 14Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 15Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 16Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 17Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 18Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 19Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 20Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 21North American Spine Partners With University General Hospital to Bring Back Pain Relief to Houston Patients 2
(Date:5/24/2013)... (PRWEB) May 24, 2013 DePuy ... hip recall continue to move forward in courts throughout ... documents filed in California’s San Francisco Superior Court on ... expedited trial of her DePuy hip lawsuit is voluntarily ... Orthopaedics, Inc., et al., No. CGC11508806; Calif. Super. Ct., ...
(Date:5/24/2013)... (HealthDay News) -- Patients hospitalized for heart failure appear ... on Mondays or in the morning, a new study ... highest among heart failure patients admitted in January, on ... scheduled to present their findings Saturday in Portugal at ... the European Society of Cardiology. "The fact ...
(Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout season ... offering tips to help prevent grill fires throughout the spring ... (NFPA) reports that gas grills led to an average of ... solid-fueled grills, meanwhile, caused approximately 1,200 home fires per year ... is sharing the following tips from the NFPA to help ...
(Date:5/24/2013)... (HealthDay News) -- New research suggests a link ... with insomnia. Every additional hour someone with ... drop in the likelihood of moderate or high ... University of Pennsylvania. "We were surprised ... duration and suicide risk," study author, Linden Oliver, ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2
... ... Acid Fillers , ... NY (Vocus) August 17, 2009 -- As one ages, the characteristics of the eyes change ... upper lid may recede or enlarge, and the bones around the eyes appear more prominent. ...
... , , WASHINGTON, Aug. ... Capitol Hill, key stakeholders meeting across town agreed that efforts ... that board certification must play an enhanced role in leading ... World," a two-day summit and call to action convened by ...
... Twelve hospitals to be awarded a total of $363,801 ... , , ARLINGTON, Texas, Aug. 17 ... from the Centers for Medicare & Medicaid Services (CMS) for performing ... The 12 Texas Health hospitals participating in the project will ...
... Elsevier, the leading publisher of scientific, technical and medical ... Midwifery & Women,s Health (JMWH), the official journal ... authors for their outstanding contributions to the Journal in ... CNM, commented, "We are extremely pleased to be able ...
... , PRINCETON, N.J., Aug. 17 Derma S ... provider of advanced wound care products, reports results today for the second quarter and ... second quarter and six months ended June 30, 2009: , , ... $664,766 in second quarter 2009, versus $295,315 in 2008. For the six months ended ...
... ... prospective patients an idea of what the future can hold. Dr. Jack P. Gunter and ... a view of what they think would look best for that particular patient after ... ...
Cached Medicine News:Health News:Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 2Health News:Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 3Health News:ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement 2Health News:ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement 3Health News:ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement 4Health News:ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement 5Health News:ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement 6Health News:Texas Health Hospitals to Receive Financial Awards for Quality 2Health News:Texas Health Hospitals to Receive Financial Awards for Quality 3Health News:Journal of Midwifery & Women's Health honors outstanding authors 2Health News:Derma Sciences Reports Second Quarter 2009 Results 2Health News:Derma Sciences Reports Second Quarter 2009 Results 3Health News:Derma Sciences Reports Second Quarter 2009 Results 4Health News:Derma Sciences Reports Second Quarter 2009 Results 5Health News:Derma Sciences Reports Second Quarter 2009 Results 6Health News:Derma Sciences Reports Second Quarter 2009 Results 7Health News:Derma Sciences Reports Second Quarter 2009 Results 8Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 4
The Ultra HDL (UHDL) assay is used for the quantitation of high density lipoprotein (HDL) cholesterol in human serum or plasma....
The Tissue Cassette Storage Cabinet is made of strong, laminated fiberboard....
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Scienceware® Slide Tray Cabinet holds twelve Scienceware® H44581 microscope trays horizontally in a dust free enclosure....
Medicine Products: